DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2324291/compared-to-estimates-medtronic-mdt-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2324291 Aug 20, 2024 - Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.fool.com/investing/2024/08/17/3-dividend-stocks-to-double-up-on-right-now/?source=iedfolrf0000001 Aug 17, 2024 - How does a 5.7% dividend yield sound? 0

https://www.zacks.com/stock/news/2322671/medtronic-mdt-progresses-in-cgm-with-new-approval-alliance?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322671 Aug 15, 2024 - The FDA approval for Medtronic's (MDT) Simplera CGM sets the stage for further regulatory submissions of the updated InPen smart insulin pen app. 0

https://www.zacks.com/stock/news/2322493/seeking-clues-to-medtronic-mdt-q1-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2322493 Aug 15, 2024 - Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2322505/masimo-s-masi-w1-watch-gains-fda-nod-for-safetynet-connectivity?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322505 Aug 15, 2024 - The latest FDA clearance of Masimo's (MASI) W1 medical watch is likely to provide a continuous and accurate view of patients' health data. 0

https://www.zacks.com/stock/news/2321881/im-cannabis-corp-imcc-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2321881 Aug 14, 2024 - IM Cannabis (IMCC) delivered earnings and revenue surprises of 79.76% and 12.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2321482/abbott-up-7-7-post-q2-earnings-should-you-buy-abt-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321482 Aug 13, 2024 - Abbott's (ABT) strong growth projection for 2024 is an indication that the stock will be able to sustain the positive momentum through the rest of the year. 0

https://www.zacks.com/stock/news/2313497/medtronic-mdt-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2313497 Jul 31, 2024 - Medtronic (MDT) closed at $80.32 in the latest trading session, marking a -0.61% move from the prior day. 0

https://www.fool.com/investing/2024/07/16/how-much-will-medtronic-pay-out-in-dividends-this/?source=iedfolrf0000001 Jul 16, 2024 - The short answer: More than many of its peers, at least in terms of yield. 0

https://www.zacks.com/commentary/2299156/top-stock-reports-for-novo-nordisk-abbvie-astrazeneca?cid=CS-ZC-FT-research_daily-2299156 Jul 10, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AbbVie Inc. (ABBV) and AstraZeneca PLC (AZN), as well as two micro-cap stocks, Air T, Inc. (AIRT) and United-Guardian, Inc. (UG). 0